Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma
Shinji Tanaka, … , Keizo Sugimachi, Jack R. Wands
Shinji Tanaka, … , Keizo Sugimachi, Jack R. Wands
Published February 1, 1999
Citation Information: J Clin Invest. 1999;103(3):341-345. https://doi.org/10.1172/JCI4891.
View: Text | PDF
Article Article has an altmetric score of 12

Biologic significance of angiopoietin-2 expression in human hepatocellular carcinoma

  • Text
  • PDF
Abstract

Human hepatocellular carcinoma (HCC) is generally a highly vascular tumor, but the mechanisms of neovascularization that permit rapid growth have not been defined. Angiopoietins (Ang) recently have been identified as ligands for vascular endothelial-specific Tie2 receptor tyrosine kinase and may be important growth factors in the generation of new blood vessels. We investigated Ang expression in 23 samples of HCC and paired adjacent uninvolved liver samples to determine if these genes have a potential role in the growth and spread of this disease. The full coding sequence of a variant angiopoietin-2 (Ang2) cDNA was obtained from HCC specimens, and the biologic consequences of overexpression on tumor formation and hemorrhage were determined in an animal model system. Angiopoietin-1 (Ang1) was equally expressed in HCC and adjacent noncarcinomatous liver tissue. Surprisingly, Ang2 was found to be highly expressed only in tumor tissue. In addition, Ang2 was expressed in 10 of 12 hypervascular HCC, but only in 2 of 11 hypovascular HCC. Ectopic expression of Ang2 in nonexpressing HCC cells promotes the rapid development of human hepatomas and produces hemorrhage within tumors in nude mice. These results suggest a role for Ang2 in the neovascularization of HCC. This enhanced gene expression may contribute to the clinical hypervascular phenotype, as well as tumor formation and progression.

Authors

Shinji Tanaka, Masaki Mori, Yoshihiro Sakamoto, Masatoshi Makuuchi, Keizo Sugimachi, Jack R. Wands

×

Total citations by year

Year: 2025 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 Total
Citations: 1 1 4 2 1 5 3 4 2 6 8 6 3 8 21 12 9 15 14 14 13 12 8 11 3 186
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (186)

Title and authors Publication Year
New insights into biomarkers and risk stratification to predict hepatocellular cancer
Li K, Mathew B, Saldanha E, Ghosh P, Krainer AR, Dasarathy S, Huang H, Xiang X, Mishra L
Molecular Medicine 2025
The clinical value of angiopoietin-2 in liver diseases.
Farshidpour M, Pace S, Volk ML
Clinical Liver Disease 2022
In Uveal Melanoma, Angiopoietin-2 but Not Angiopoietin-1 Is Increased in High-Risk Tumors, Providing a Potential Druggable Target
AM ten Voorde, AP Wierenga, RJ Nell, PA van der Velden, GP Luyten, RM Verdijk, MJ Jager
Cancers 2021
KYP-2047, an Inhibitor of Prolyl-Oligopeptidase, Reduces GlioBlastoma Proliferation through Angiogenesis and Apoptosis Modulation
SA Scuderi, G Casili, A Ardizzone, S Forte, L Colarossi, S Sava, I Paterniti, E Esposito, S Cuzzocrea, M Campolo
Cancers 2021
Utility of serum neuropilin-1 and angiopoietin-2 as markers of hepatocellular carcinoma
MT Ghafar, RA Elkhouly, MH Elnaggar, MM Mabrouk, SA Darwish, RL Younis, RA Elkholy
Journal of Investigative Medicine 2021
Serum Angiopoietin 2 acts as a diagnostic and prognostic biomarker in hepatocellular carcinoma
J Ao, T Chiba, H Kanzaki, K Kanayama, S Shibata, A Kurosugi, T Iwanaga, M Kan, T Sakuma, N Qiang, Y Ma, R Kojima, Y Kusakabe, M Nakamura, K Kobayashi, S Kiyono, N Kanogawa, T Saito, R Nakagawa, T Kondo, S Ogasawara, E Suzuki, S Nakamoto, R Muroyama, A Tawada, J Kato, T Kanda, H Maruyama, N Kato
Journal of Cancer 2021
The Angiopoietin/Tie2 Pathway in Hepatocellular Carcinoma
B Vanderborght, S Lefere, HV Vlierberghe, L Devisscher
Cells 2020
Expression of Angiopoietins and Angiogenic Signaling Pathway Molecules in Chronic Subdural Hematomas
T Isaji, K Osuka, Y Ohmichi, M Ohmichi, M Naito, T Nakano, K Iwami, S Miyachi
Journal of Neurotrauma 2020
Anti-angiogenic Targets: Angiopoietin and Angiopoietin Receptors
Kiss EA, Saharinen P
Tumor Angiogenesis 2019
Precision medicine based on surgical oncology in the era of genome-scale analysis and genome editing technology
S Tanaka
Annals of Gastroenterological Surgery 2018
The Role of Angiogenesis in Colorectal Polyps and Cancer, a Review
HA Aghdaei, Z Pezeshkian, M Abdollahpour-Alitappeh, EN Mojarad, MR Zali
2018
Tumor Angiogenesis: A Key Target for Cancer Therapy
D Marmé
Tumor Angiogenesis 2018
Advances in genomic hepatocellular carcinoma research
W Huang, AJ Skanderup, CG Lee
GigaScience 2018
Clinical and prognostic significance of circulating levels of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
RC Pestana, MM Hassan, R Abdel-Wahab, YI Abugabal, LM Girard, D Li, P Chang, K Raghav, J Morris, RA Wolff, A Rashid, HM Amin, A Kaseb
Oncotarget 2018
Vascular Mimicry: A Novel Neovascularization Mechanism Driving Anti-Angiogenic Therapy (AAT) Resistance in Glioblastoma
K Angara, TF Borin, AS Arbab
Translational oncology 2017
Intrahepatic angiopoietin-2 correlates with chronic hepatitis C progression and is induced in hepatitis C virus replicon systems
Á Hernández-Bartolomé, R López-Rodríguez, L García-Buey, S Martín-Vílchez, Y Rodríguez-Muñoz, MJ Borque, L González-Moreno, Y Real-Martínez, J Mendoza-Ridruejo, E Martín-Pérez, R Moreno-Otero, P Sanz-Cameno
Liver International 2017
Angiogenesis Dysregulation in Psoriatic Arthritis: Molecular Mechanisms
FP Cantatore, N Maruotti, A Corrado, D Ribatti
BioMed Research International 2017
Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease
KG Blecharz, D Frey, T Schenkel, V Prinz, G Bedini, SM Krug, M Czabanka, J Wagner, M Fromm, A Bersano, P Vajkoczy
Journal of Cerebral Blood Flow & Metabolism 2016
Phase II trial of bevacizumab and erlotinib as a second-line therapy for advanced hepatocellular carcinoma
A Kaseb, J Morris, M Iwasaki, H Al-Shamsi, K Raghav, L Girard, S Cheung, V Nguyen, K Elsayes, L Xiao, R Abdel-Wahab, A Shalaby, M Hassan, H Hassabo, R Wolff, J Yao
OncoTargets and therapy 2016
Infectious Angiogenesis—Different Pathways, the Same Goal:
M Urbanowicz, H Kutzner, E Riveiro-Falkenbach, JL Rodriguez-Peralto
The American Journal of Dermatopathology 2016
Autocrine release of angiopoietin-2 mediates cerebrovascular disintegration in Moyamoya disease
KG Blecharz, D Frey, T Schenkel, V Prinz, G Bedini, SM Krug, M Czabanka, J Wagner, M Fromm, A Bersano, P Vajkoczy
Journal of Cerebral Blood Flow & Metabolism 2016
Neoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective study
E Villa, R Critelli, B Lei, G Marzocchi, C Cammà, G Giannelli, P Pontisso, G Cabibbo, M Enea, S Colopi, C Caporali, T Pollicino, F Milosa, A Karampatou, P Todesca, E Bertolini, L Maccio, ML Martinez-Chantar, E Turola, MD Buono, ND Maria, S Ballestri, F Schepis, P Loria, GE Gerunda, L Losi, U Cillo
Gut 2015
Chesley's Hypertensive Disorders in Pregnancy
SJ Fisher, M McMaster, JM Roberts
Chesley's Hypertensive Disorders in Pregnancy 2015
Role of Angiopoietin-2 in Corneal Lymphangiogenesis
D Yuen, S Grimaldo, R Sessa, T Ecoiffier, T Truong, E Huang, M Bernas, S Daley, M Witte, L Chen
Investigative ophthalmology & visual science 2014
PHIPing Out: A Genetic Basis for Tumor Ulceration
JL Arbiser
Journal of Investigative Dermatology 2014
Effect of the vascular endothelial growth factor expression level on angiopoietin-2-mediated nasopharyngeal carcinoma growth
HH Chen, BQ Weng, KJ Cheng, HY Liu, SQ Wang, YY Lu
Vascular cell 2014
Circulating pro- and anti-angiogenic mediators in patients infected with hepatitis C at different stages of hepatocellular carcinoma: Angiogenesis in HCC Patients
RM Talaat, TA Salem, S El-Masry, A Imbarek, M Mokhles, A Abdel-Aziz
Journal of Medical Virology 2014
Overexpression of angiopoietin-2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition
M Pauta, J Ribera, P Melgar-Lesmes, G Casals, J Rodríguez-Vita, V Reichenbach, G Fernandez-Varo, B Morales-Romero, R Bataller, J Michelena, J Altamirano, W Jiménez, M Morales-Ruiz
Liver International 2014
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectives
A Kaseb, F Janku, M Bupathi
OncoTargets and therapy 2014
Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
K Miyahara, K Nouso, Y Morimoto, Y Takeuchi, H Hagihara, K Kuwaki, H Onishi, F Ikeda, Y Miyake, S Nakamura, H Shiraha, A Takaki, M Honda, S Kaneko, T Sato, S Sato, S Obi, S Iwadou, Y Kobayashi, K Takaguchi, K Kariyama, Y Takuma, H Takabatake, K Yamamoto, K Yamamoto, Y Morimoro, Y Takeuchi, K Miyahara, H Hagihara, K Kuwaki, H Onishi, S Nakamura, H Shiraha, K Nouso, Y Takuma, H Takabatake, Y Morimoto, S Fujioka, T Osawa, K Kariyama, J Toshimori, H Kobashi, H Miyatake, S Iwadou, Y Kobayashi, S Uematsu, R Okamoto, Y Araki, M Tatsukawa, K Yabushita, T Shimoe, K Sakaguchi, T Sakata, T Kaneyoshi, M Miyashita, Y Makino, A Moriya, M Ando, N Baba, T Seno, T Nagano, K Takaguchi, E Matsumoto, H Takayama
British Journal of Cancer 2013
Angiopoietin-2 expression is correlated with angiogenesis and overall survival in oral squamous cell carcinoma
C Li, C Sun, J Fan, N Geng, C Li, J Liao, K Mi, G Zhu, H Ma, Y Song, Y Tang, Y Chen
Medical Oncology 2013
Serum angiopoietin-2 level as a predictor of tumor invasiveness in patients with hepatocellular carcinoma
A Diaz-Sanchez, A Matilla, O Nuñez, R Lorente, A Fernandez, D Rincón, R Campos, R Bañares, G Clemente
Scandinavian Journal of Gastroenterology 2013
Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation
T Li, Z Liu, K Jiang, Q Ruan
Cancer Letters 2013
Putative effects of potentially anti-angiogenic drugs in rheumatic diseases
N Maruotti, FP Cantatore, D Ribatti
European Journal of Clinical Pharmacology 2013
Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link
A Hernández-Bartolomé, R López-Rodríguez, Y Rodríguez-Muñoz, S Martín-Vílchez, MJ Borque, L García-Buey, L González-Moreno, Y Real, R Moreno-Otero, P Sanz-Cameno
PloS one 2013
Gene expression of growth factors and growth factor receptors for potential targeted therapy of canine hepatocellular carcinoma
G Iida, K Asano, M Seki, M Sakai, K Kutara, K Ishigaki, Y Kagawa, O Yoshida, K Teshima, K Edamura, T Watari
Journal of Veterinary Medical Science 2013
Angiopoietin-2 Serum Levels Improve Noninvasive Fibrosis Staging in Chronic Hepatitis C: A Fibrogenic-Angiogenic Link
Á Hernández-Bartolomé, R López-Rodríguez, Y Rodríguez-Muñoz, S Martín-Vílchez, MJ Borque, L García-Buey, L González-Moreno, Y Real, R Moreno-Otero, P Sanz-Cameno, JP Vartanian
PloS one 2013
Adenoviral gene therapy in hepatocellular carcinoma: a review
I Lyra-González, LE Flores-Fong, I González-García, D Medina-Preciado, J Armendáriz-Borunda
Hepatology International 2012
Targeted systemic therapies for hepatocellular carcinoma: Clinical perspectives, challenges and implications
C Frenette, R Gish
World journal of gastroenterology : WJG 2012
Des-γ-carboxyl prothrombin is associated with tumor angiogenesis in hepatocellular carcinoma: DCP and tumor angiogenesis in HCC
M Matsubara, H Shiraha, J Kataoka, M Iwamuro, S Horiguchi, S Nishina, N Takaoka, M Uemura, A Takaki, S Nakamura, Y Kobayashi, K Nouso, K Yamamoto
Journal of Gastroenterology and Hepatology 2012
Tie2-Dependent Neovascularization of the Ischemic Hindlimb Is Mediated by Angiopoietin-2
M Lekas, P Lekas, SH Mei, Y Deng, DJ Dumont, DJ Stewart
PloS one 2012
Source of angiopoietin-2 in the sera of women during pregnancy
C Woolnough, Y Wang, CY Kan, JM Morris, V Tasevski, AW Ashton
Microvascular Research 2012
Molecular Targeted Therapies in Hepatocellular Carcinoma
S Tanaka, S Arii
Seminars in Oncology 2012
Molecular targeted therapy for hepatocellular carcinoma in the current and potential next strategies
S Tanaka, S Arii
Journal of Gastroenterology 2011
Angiopoietin-2 inhibits the growth of tongue carcinoma without affecting expression of vascular endothelial growth factor
H Chen, L Chai, S Wang, Z Shi, Q Wu
International Journal of Oral and Maxillofacial Surgery 2011
AMG 386: profile of a novel angiopoietin antagonist in patients with ovarian cancer
EJ Robson, P Ghatage
Expert Opinion on Investigational Drugs 2011
Molecular targeted therapy for advanced hepatocellular carcinoma: current status and future perspectives
YC Shen, C Hsu, AL Cheng
Journal of Gastroenterology 2010
HCV-related hepatocellular carcinoma: From chronic inflammation to cancer
G Castello, S Scala, G Palmieri, SA Curley, F Izzo
Clinical Immunology 2010
Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT)
L Ojeda-Fernandez, L Barrios, A Rodriguez-Barbero, L Recio-Poveda, C Bernabeu, LM Botella
Clinica Chimica Acta 2010
Chemotherapy with PLGA microspheres containing docetaxel decreases angiogenesis in human hepatoma xenograft
Z Chen, M Cai, J Yang, L Lin, E Xue, J Huang, H Wei, X Zhang, L Ke
Medical Oncology 2010
Gene-expression phenotypes for vascular invasiveness of hepatocellular carcinomas
S Tanaka, K Mogushi, M Yasen, N Noguchi, A Kudo, N Nakamura, K Ito, Y Miki, J Inazawa, H Tanaka, S Arii
Surgery 2010
Current status of molecularly targeted therapy for hepatocellular carcinoma: basic science
S Tanaka, S Arii
International Journal of Clinical Oncology 2010
Hepatitis B virus/hepatitis C virus upregulate angiopoietin-2 expression through mitogen-activated protein kinase pathway: HBV/HCV promotes Ang-2 expression via MAPK pathway
Y Li, J Chen, C Wu, L Wang, M Lu, X Chen
Hepatology Research 2010
Hepatocellular Carcinoma:
KM McMasters
2010
Genetic and epigenetic silencing of SCARA5 may contribute to hepatocellular carcinoma by activating FAK signaling
Jian Huang, DaLi Zheng, Feng-Song Qin, Na Cheng, Hui Chen, Yu-Ping WANG, BinBin Wan, Hua-Sheng Xiao, Ze-Guang Han
Journal of Clinical Investigation 2009
Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats
M Mejias, E Garcia-Pras, C Tiani, R Miquel, J Bosch, M Fernandez
Hepatology 2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Angiogenesis Inhibition
R Liersch, WE Berdel, T Kessler
2009
Combination of interferon-alpha and 5-fluorouracil inhibits endothelial cell growth directly and by regulation of angiogenic factors released by tumor cells
H Wada, H Nagano, H Yamamoto, T Noda, M Murakami, S Kobayashi, S Marubashi, H Eguchi, Y Takeda, M Tanemura, K Umeshita, Y Doki, M Mori
BMC Cancer 2009
Cerebral arteriovenous malformations. Part 1: cellular and molecular biology
P Moftakhar, JS Hauptman, D Malkasian, NA Martin
Neurosurgical FOCUS 2009
The effects of angiopoietin-2 on the growth of tongue carcinoma
Chen, Z Shi, S Wang, Q Wu
British Journal of Oral and Maxillofacial Surgery 2009
Angiogenesis and Preeclampsia
SA Karumanchi, IE Stillman, MD Lindheimer
Chesley s Hypertensive Disorders in Pregnancy 2009
Hepatitis C virus core protein triggers hepatic angiogenesis by a mechanism including multiple pathways
M Hassan, D Selimovic, H Ghozlan, O Abdel-kader
Hepatology 2009
The role of the Angiopoietins in vascular morphogenesis
M Thomas, HG Augustin
Angiogenesis 2009
Switching of vascular phenotypes within a murine breast cancer model induced by angiopoietin-2
Y Reiss, A Knedla, AO Tal, MH Schmidt, M Jugold, F Kiessling, AM Burger, H Wolburg, U Deutsch, KH Plate
The Journal of Pathology 2009
Serum Levels of Angiopoietin-1, Angiopoietin-2, and Their Receptor Tie-2 in Patients with Nonsmall Cell Lung Cancer During Chemotherapy
W Naumnik, E Chyczewska, M Ossolinska
Cancer Investigation 2009
The Opening Act: Vasculogenesis and the Origins of Circulation
SW Jin, C Patterson
Arteriosclerosis, thrombosis, and vascular biology 2009
CNS Cancer
EG Meir
2009
Hepatic Stellate Cells Secrete Angiopoietin 1 That Induces Angiogenesis in Liver Fibrosis
K Taura, SD Minicis, E Seki, E Hatano, K Iwaisako, CH Osterreicher, Y Kodama, K Miura, I Ikai, S Uemoto, DA Brenner
Gastroenterology 2008
Application of angiogenesis to clinical dermatology
LE Fried, JL Arbiser
Advances in Dermatology 2008
Aurora kinase B is a predictive factor for the aggressive recurrence of hepatocellular carcinoma after curative hepatectomy
S Tanaka, S Arii, M Yasen, K Mogushi, NT Su, C Zhao, I Imoto, Y Eishi, J Inazawa, Y Miki, H Tanaka
British Journal of Surgery 2008
Molecularly targeted therapy for hepatocellular carcinoma
S Tanaka, S Arii
Kanzo 2008
Insulin-like growth factors, angiopoietin-2, and pigment epithelium–derived growth factor in the hypoxic retina
V Sivakumar, Y Zhang, EA Ling, WS Foulds, C Kaur
Journal of Neuroscience Research 2008
Inhibition of In Vivo Tumor Angiogenesis and Growth Via Systemic Delivery of an Angiopoietin 2-Specific RNA Aptamer
S Sarraf-Yazdi, J Mi, BJ Moeller, X Niu, RR White, CD Kontos, BA Sullenger, MW Dewhirst, BM Clary
Journal of Surgical Research 2008
The angiogenic makeup of human hepatocellular carcinoma does not favor vascular endothelial growth factor/angiopoietin-driven sprouting neovascularization
W Zeng, AS Gouw, MC van Heuvel, PJ Zwiers, PE Zondervan, S Poppema, N Zhang, I Platteel, KP de Jong, G Molema
Hepatology 2008
Pelioid-type hepatocellular carcinoma with numerous eosinophilic infiltrations in a patient with primary biliary cirrhosis
T Watanabe, K Aikawa, T Kanefuji, K Yamazaki, H Hirono, K Hasegawa, K Soga, K Shibasaki, H Umezu, M Nomoto
Hepatology Research 2008
Vascular Changes in Hepatocellular Carcinoma
ZF Yang, RT Poon
The Anatomical Record Advances in Integrative Anatomy and Evolutionary Biology 2008
Angiopoietin-2 levels in the hepatic vein as a useful predictor of tumor invasiveness and prognosis in human hepatocellular carcinoma
S Kuboki, H Shimizu, N Mitsuhashi, K Kusashio, F Kimura, H Yoshidome, M Ohtsuka, A Kato, H Yoshitomi, M Miyazaki
Journal of Gastroenterology and Hepatology 2008
Antiangiogenic Agents in Cancer Therapy
BA Teicher, LM Ellis
2008
Quantum Dot Self-Assembly for Protein Detection with Sub-Picomolar Sensitivity
CP Soman, TD Giorgio
Langmuir 2008
Why targeted therapy hasn’t worked in advanced cancer
Jack L. Arbiser
Journal of Clinical Investigation 2007
Kaposi's sarcoma-associated herpesvirus promotes angiogenesis by inducing angiopoietin-2 expression via AP-1 and Ets1
FC Ye, DJ Blackbourn, M Mengel, JP Xie, LW Qian, W Greene, IT Yeh, D Graham, SJ Gao
Journal of virology 2007
Differential response of lymphatic, venous and arterial endothelial cells to angiopoietin-1 and angiopoietin-2
VP Nguyen, SH Chen, J Trinh, H Kim, BL Coomber, DJ Dumont
BMC cell biology 2007
Perspectives in Medical Virology
KD Mena
Perspectives in Medical Virology 2007
Molecular targeted therapy for advanced hepatocellular carcinoma
YC Shen, C Hsu, AL Cheng
Targeted Oncology 2007
Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis: MicroRNA in HCC
YS Huang, Y Dai, XF Yu, SY Bao, YB Yin, M Tang, CX Hu
Journal of Gastroenterology and Hepatology 2007
Microarray-based analysis for hepatocellular carcinoma: from gene expression profiling to new challenges
Y Midorikawa, M Makuuchi, W Tang, H Aburatani
World journal of gastroenterology : WJG 2007
Levels of soluble vascular endothelial growth factor receptor 1 are elevated in the exudative pleural effusions
H Tomimoto, S Yano, H Muguruma, S Kakiuchi, S Sone
The Journal of Medical Investigation 2007
From Molecular Biology to Targeted Therapies for Hepatocellular Carcinoma: The Future Is Now
RW Pang, RT Poon
Oncology 2007
Hepatitis B virus promotes angiopoietin-2 expression in liver tissue: role of HBV x protein
P Sanz-Cameno, S Martín-Vílchez, E Lara-Pezzi, MJ Borque, J Salmerón, PM de Rueda, JA Solís, M López-Cabrera, R Moreno-Otero
The American Journal of Pathology 2006
Current status and perspective of antiangiogenic therapy for cancer: hepatocellular carcinoma
S Tanaka, S Arii
International Journal of Clinical Oncology 2006
Pharmacologic Blockade of Angiopoietin-2 Is Efficacious against Model Hemangiomas in Mice
BN Perry, B Govindarajan, SS Bhandarkar, UG Knaus, M Valo, C Sturk, CO Carrillo, A Sohn, F Cerimele, D Dumont, A Losken, J Williams, LF Brown, X Tan, E Ioffe, GD Yancopoulos, JL Arbiser
Journal of Investigative Dermatology 2006
Specific Peptide Ligand for Grb7 Signal Transduction Protein and Pancreatic Cancer Metastasis
S Tanaka, SC Pero, K Taguchi, M Shimada, M Mori, DN Krag, S Arii
JNCI Journal of the National Cancer Institute 2006
Viral hepatitis and liver cancer: the case of hepatitis C
M Levrero
Oncogene 2006
A Comparison of Antiangiogenic Therapies for the Prevention of Liver Metastases
J Mi, S Sarraf-Yazdi, X Zhang, Y Cao, MW Dewhirst, CD Kontos, CY Li, BM Clary
Journal of Surgical Research 2006
Antibodies and antibody-fusion proteins as anti-angiogenic, anti-tumor agents
CI Calfa, JD Rosenblatt, HM Cho, K Webster, SU Shin
Update on cancer therapeutics 2006
Induction of Angiopoietin-2 gene expression by COX-2: A novel role for COX-2 inhibitors during hepatocarcinogenesis
S Tanaka, JR Wands, S Arii
Journal of Hepatology 2006
Gene expressions of canine angiopoietin-1 and -2 in normal tissues and spontaneous tumours
Y Kato, K Asano, I Mizutani, T Konno, Y Sasaki, K Kutara, K Teshima, K Edamura, R Kano, K Suzuki, H Shibuya, T Sato, A Hasegawa, S Tanaka
Research in Veterinary Science 2006
Angiogenesis and anti-angiogenesis in hepatocellular carcinoma
D Ribatti, A Vacca, B Nico, D Sansonno, F Dammacco
Cancer Treatment Reviews 2006
Transgenic expression of Angiopoietin 1 in the liver leads to changes in lymphatic and blood vessel architecture
AL Haninec, D Voskas, A Needles, AS Brown, FS Foster, DJ Dumont
Biochemical and Biophysical Research Communications 2006
The Duality of Angiogenesis: Implications for Therapy of Human Disease
BN Perry, JL Arbiser
Journal of Investigative Dermatology 2006
Immunohistochemical detection of platelet-derived endothelial cell growth factor/thymidine phosphorylase and angiopoietins in ameloblastic tumors
H Kumamoto, K Ooya
Journal of Oral Pathology and Medicine 2006
Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma
R Pang, RT Poon
Cancer Letters 2006
Chronic systemic delivery of angiopoietin-2 reveals a possible independent angiogenic effect
W Bureau, PV Slyke, J Jones, RN Han, NL Ward, DJ Stewart, DJ Dumont
American journal of physiology. Heart and circulatory physiology 2006
Hepatic Tumor Growth: Target for Angiogenesis Inhibition?
S Sarraf-Yazdi, J Mi, BM Clary
World Journal of Surgery 2005
Angiopoietin 2 displays a vascular endothelial growth factor dependent synergistic effect in hepatocellular carcinoma development in mice
H Yoshiji, S Kuriyama, R Noguchi, J Yoshii, Y Ikenaka, K Yanase, T Namisaki, M Kitade, M Uemura, T Masaki, H Fukui
Gut 2005
Ephrin-A1 expression contributes to the malignant characteristics of {alpha}-fetoprotein producing hepatocellular carcinoma
H Iida, M Honda, HF Kawai, T Yamashita, Y Shirota, BC Wang, H Miao, S Kaneko
Gut 2005
Pathophysiology of tumor neovascularization
M Furuya, M Nishiyama, Y Kasuya, S Kimura, H Ishikura
Vascular Health and Risk Management 2005
The Role of Angiopoietins During Angiogenesis in Gliomas
Y Reiss, MR Machein, KH Plate
Brain Pathology 2005
Angiopoietin-1 and Myeloma-Induced Angiogenesis
N Giuliani, S Colla, F Morandi, V Rizzoli
Leukemia & Lymphoma 2005
Systemic soluble Tie2 expression inhibits and regresses corneal neovascularization
N Singh, E Macnamara, S Rashid, J Ambati, CD Kontos, E Higgins, BK Ambati
Biochemical and Biophysical Research Communications 2005
The role of cytokines and trophic factors in epiretinal membranes: involvement of signal transduction in glial cells
C Harada, Y Mitamura, T Harada
Progress in Retinal and Eye Research 2005
Review article: angiogenesis soluble factors as liver disease markers
X Salcedo, J Medina, P Sanz-Cameno, L Garcia-Buey, S Martin-Vilchez, R Moreno-Otero
Alimentary Pharmacology & Therapeutics 2005
Expression of angiopoietin-1 and -2, and its clinical significance in human bladder cancer
N Oka, Y Yamamoto, M Takahashi, M Nishitani, HO Kanayama, S Kagawa
BJU International 2005
Pathogenesis of hepatocellular carcinoma:
D Moradpour, HE Blum
European Journal of Gastroenterology & Hepatology 2005
Anti-Angiogenic Treatment of Gastrointestinal Malignancies
JS Salmon, AC Lockhart, J Berlin
Cancer Investigation 2005
Absence of Smooth Muscle Actin-Positive Pericyte Coverage of Tumor Vessels Correlates with Hematogenous Metastasis and Prognosis of Colorectal Cancer Patients
Y Yonenaga, A Mori, H Onodera, S Yasuda, H Oe, A Fujimoto, T Tachibana, M Imamura
Oncology 2005
Hepatocellular Cancer
BI Carr
2005
Angiopoietin-1 causes reversible degradation of the portal microcirculation in mice: implications for treatment of liver disease
NL Ward, AL Haninec, PV Slyke, JG Sled, C Sturk, RM Henkelman, IR Wanless, DJ Dumont
The American Journal of Pathology 2004
The role of angiopoietins in the development of endothelial cells from cord blood CD34+ progenitors
P Hildbrand, V Cirulli, RC Prinsen, KA Smith, BE Torbett, DR Salomon, L Crisa
Blood 2004
Overexpression of angiopoietin-1 and angiopoietin-2 in hepatocellular carcinoma
T Torimura, T Ueno, M Kin, R Harada, E Taniguchi, T Nakamura, R Sakata, O Hashimoto, M Sakamoto, R Kumashiro, M Sata, O Nakashima, H Yano, M Kojiro
Journal of Hepatology 2004
Angiopoietin-1 promotes tumor angiogenesis in a rat glioma model
MR Machein, A Knedla, R Knoth, S Wagner, E Neuschl, KH Plate
The American Journal of Pathology 2004
Hepatic expression ofANG2 RNA in metastatic colorectal cancer
M Ogawa, H Yamamoto, H Nagano, Y Miyake, Y Sugita, T Hata, B Kim, CY Ngan, B Damdinsuren, M Ikenaga, M Ikeda, M Ohue, S Nakamori, M Sekimoto, M Sakon, N Matsuura, M Monden
Hepatology 2004
Suppression of angiogenesis and tumor growth by selective inhibition of angiopoietin-2
J Oliner, H Min, J Leal, D Yu, S Rao, E You, X Tang, H Kim, S Meyer, SJ Han, N Hawkins, R Rosenfeld, E Davy, K Graham, F Jacobsen, S Stevenson, J Ho, Q Chen, T Hartmann, M Michaels, M Kelley, L Li, K Sitney, F Martin, JR Sun, N Zhang, J Lu, J Estrada, R Kumar, A Coxon, S Kaufman, J Pretorius, S Scully, R Cattley, M Payton, S Coats, L Nguyen, B Desilva, A Ndifor, I Hayward, R Radinsky, T Boone, R Kendall
Cancer Cell 2004
Pathobiology of Human Cerebrovascular Malformations: Basic Mechanisms and Clinical Relevance
J Gault, H Sarin, NA Awadallah, R Shenkar, IA Awad
Neurosurgery 2004
Role of vascular endothelial growth factor on the invasive potential of hepatocellular carcinoma
S Arii
Journal of Hepatology 2004
Autocrine/paracrine role of the angiopoietin-1 and -2/Tie2 system in cell proliferation and chemotaxis of cultured fibroblastic synoviocytes in rheumatoid arthritis
K Takahara, T Iioka, K Furukawa, T Uchida, M Nakashima, T Tsukazaki, H Shindo
Human Pathology 2004
Identification of Molecular Markers Specific for Pancreatic Neuroendocrine Tumors by Genetic Profiling of Core Biopsies
M Bloomston, A Durkin, I Yang, M Rojiani, AS Rosemurgy, S Enkmann, TJ Yeatman, EE Zervos
Annals of Surgical Oncology 2004
Role of Ang1 and Its Interaction with VEGF-A in Astrocytomas
G Zadeh, K Koushan, L Pillo, P Shannon, A Guha
Journal of Neuropathology and Experimental Neurology 2004
Expression and significance of angiopoietin-2 in gastric cancer
Xiao-Dong Sun, Xing-E Liu, Jin-Min Wu, Xiu-Jun Cai, Yi-Ping Mou, Jun-Da Li
World journal of gastroenterology : WJG 2004
Mathematical modeling of tumor-induced angiogenesis
NV Mantzaris, S Webb, HG Othmer
Journal of Mathematical Biology 2004
Angiogenesis in hepatocellular carcinoma: the retrospectives and perspectives
HC Sun, ZY Tang
Journal of Cancer Research and Clinical Oncology 2004
Inhibition of rat corneal angiogenesis by a nuclease-resistant RNA aptamer specific for angiopoietin-2
RR White, S Shan, CP Rusconi, G Shetty, MW Dewhirst, CD Kontos, BA Sullenger
Proceedings of the National Academy of Sciences 2003
Expression of genes regulating angiogenesis in human circulating hematopoietic cord blood CD34+/CD133+ cells
J Pomyje, J Zivny, L Sefc, M Plasilova, R Pytlik, E Necas
European Journal of Haematology 2003
Infectious angiogenesis: Bartonella bacilliformis infection results in endothelial production of angiopoetin-2 and epidermal production of vascular endothelial growth factor
F Cerimele, LF Brown, F Bravo, GM Ihler, P Kouadio, JL Arbiser
The American Journal of Pathology 2003
Angiopoietin switching regulates angiogenesis and progression of human hepatocellular carcinoma
K Sugimachi, S Tanaka, K Taguchi, S Aishima, M Shimada, M Tsuneyoshi
Journal of clinical pathology 2003
Angiopoietins in angiogenesis and beyond
S Tsigkos, M Koutsilieris, A Papapetropoulos
Expert Opinion on Investigational Drugs 2003
Not just angiogenesis?wider roles for the angiopoietins
PF Jones
The Journal of Pathology 2003
Gene Therapy for Hepatocellular Carcinoma
PY Lam
Cancer Reviews: Asia-Pacific 2003
The Kidney
LM Satlin, CB Woda, GJ Schwartz
The Kidney 2003
Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells
N Giuliani, S Colla, M Lazzaretti, R Sala, G Roti, C Mancini, S Bonomini, P Lunghi, M Hojden, G Genestreti, M Svaldi, P Coser, PP Fattori, G Sammarelli, GC Gazzola, R Bataille, C Almici, C Caramatti, L Mangoni, V Rizzoli
Haematologica 2003
Expressions of vascular endothelial growth factor and angiopoietin-2 in myeloma cells
N Giuliani, S Colla, M Lazzaretti, R Sala, G Roti, C Mancini, S Bonomini, P Lunghi, M Hojden, G Genestreti, M Svaldi, P Coser, PP Fattori, G Sammarelli, GC Gazzola, R Bataille, C Almici, C Caramatti, L Mangoni, V Rizzoli
Haematologica 2003
Reversing the Angiogenic Switch with Photodynamic Therapy
JL Arbiser
Journal of Investigative Dermatology 2003
Expression of Tie-2 in human peripheral and autonomic nervous system
S Poncet, JM Gasc, RC Janzer, S Meyer, L Juillerat-Jeanneret
Neuropathology and Applied Neurobiology 2003
Angiopoietins and Tie-2 expression in angiogenesis and proliferation of human hepatocellular carcinoma
N Mitsuhashi
Hepatology 2003
Tie2 vascular endothelial receptor expression and function in hepatocellular carcinoma
S Tanaka, K Sugimachi, YY Yi, T Ohga, K Shirabe, M Shimada, JR Wands, K Sugimachi
Hepatology 2002
Stabilization of breast cancer xenograft tumour neovasculature by angiopoietin-1
S Tian, AJ Hayes, LJ Metheny-Barlow, LY Li
British Journal of Cancer 2002
Angiogenesis, thrombospondin, and ductal carcinoma in situ of the breast
A Rice, CM Quinn
Journal of clinical pathology 2002
Activation of the tie2 receptor by angiopoietin-1 enhances tumor vessel maturation and impairs squamous cell carcinoma growth
T Hawighorst, M Skobe, M Streit, YK Hong, P Velasco, LF Brown, L Riccardi, B Lange-Asschenfeldt, M Detmar
The American Journal of Pathology 2002
Extensive Oligonucleotide Microarray Transcriptome Analysis of the Rat Cerebral Artery and Arachnoid Tissue
H Wada, K Hashimoto, Y Wada, M Kobayashi, A Izumi, A Sugiyama, T Kohro, T Hamakubo, T Kodama
Journal of Atherosclerosis and Thrombosis 2002
Oncogenic signal transduction and therapeutic strategy for hepatocellular carcinoma
S Tanaka, K Sugimachi, S Maehara, N Harimoto, K Shirabe, JR Wands, K Sugimachi
Surgery 2002
The mechanisms of angiogenesis in hepatocellular carcinoma: Angiogenic switch during tumor progression
K Sugimachi, S Tanaka, T Terashi, K Taguchi, T Rikimaru, K Sugimachi
Surgery 2002
Thrombin induces increased expression and secretion of angiopoietin-2 from human umbilical vein endothelial cells
YQ Huang, JJ Li, L Hu, M Lee, S Karpatkin
Blood 2002
Regulation of angiopoietin and Tie-2 receptor expression in non-reproductive tissues by estrogen
F Ye, M Florian, SA Magder, SN Hussain
Steroids 2002
Hepatocellular carcinoma--cause, treatment and metastasis
Z Y Tang
World journal of gastroenterology : WJG 2002
Molekularmedizinische Grundlagen von nicht-hereditären Tumorerkrankungen
D Ganten, K Ruckpaul, SA Hahn, W Schmiegel
2002
Angiopoietin 2 stimulates migration and tube-like structure formation of murine brain capillary endothelial cells through c-Fes and c-Fyn
Y Mochizuki, T Nakamura, H Kanetake, S Kanda
Journal of cell science 2002
Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells
Y Yu, J Varughese, LF Brown, JB Mulliken, J Bischoff
The American Journal of Pathology 2001
Angiopoietin-1, angiopoietin-2 and Tie-2 in tumour and non-tumour tissues during growth of experimental melanoma
J Pomyje, JH Živný, T Stopka, J Šimák, H Vaňková, E Nečas
Melanoma Research 2001
Inhibition of angiopoietin-1 expression in tumor cells by an antisense RNA approach inhibited xenograft tumor growth in immunodeficient mice
WS Shim, M Teh, PO Mack, R Ge
International Journal of Cancer 2001
Angiotensin II induces expression of the Tie2 receptor ligand, angiopoietin-2, in bovine retinal endothelial cells
A Otani, H Takagi, H Oh, S Koyama, Y Honda
Diabetes 2001
Expression of angiopoietin-2 gene and its receptor Tie2 in hepatocellular carcinoma
C Libo, Y Zhen, W Guobin, W Chunyou
Journal of Tongji Medical University 2001
Differential expression of angiopoietin-1 and angiopoietin-2 in colon carcinoma: A possible mechanism for the initiation of angiogenesis
SA Ahmad, W Liu, YD Jung, F Fan, N Reinmuth, CD Bucana, LM Ellis
Cancer 2001
Hepatocellular Carcinoma-Cause, Treatment and Metastasis
ZY Tang
World journal of gastroenterology : WJG 2001
Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats
K Abdulmalek, F Ashur, N Ezer, F Ye, S Magder, SN Hussain
American journal of physiology. Lung cellular and molecular physiology 2001
Tumor Angiogenesis
M Detmar
Journal of Investigative Dermatology Symposium Proceedings 2000
Hypoxia up-regulates angiopoietin-2, a Tie-2 ligand, in mouse mesangial cells
HT Yuan, SP Yang, AS Woolf
Kidney International 2000
Angiopoietin/Tie receptor system: emerging targets for therapeutic angiogenesis and anti-angiogenic therapy
G Siemeister
Expert Opinion on Therapeutic Targets 2000
Is angiogenesis inhibition the Holy Grail of cancer therapy?
T Boehm-Viswanathan
Current Opinion in Oncology 2000
The discovery of angiogenic factors:
D Ribatti, A Vacca, M Presta
General Pharmacology: The Vascular System 2000
New molecular mediators in tumor angiogenesis
WD Beecken, W Kramer, D Jonas
Journal of Cellular and Molecular Medicine 2000
Tumor Necrosis Factor-α Upregulates Angiopoietin-2 in Human Umbilical Vein Endothelial Cells
I Kim, JH Kim, YS Ryu, M Liu, GY Koh
Biochemical and Biophysical Research Communications 2000
The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas
MP Wong, SY Chan, KH Fu, SY Leung, N Cheung, ST Yuen, LP Chung
Lung Cancer 2000
Characterization and Expression of a Novel Alternatively Spliced Human Angiopoietin-2
I Kim, JH Kim, YS Ryu, SH Jung, JJ Nah, GY Koh
The Journal of biological chemistry 2000
Angiopoietin-2 at high concentration can enhance endothelial cell survival through the phosphatidylinositol 3′-kinase/Akt signal transduction pathway
I Kim, JH Kim, SO Moon, HJ Kwak, NG Kim, GY Koh
Oncogene 2000
Angiopoietin-2 Is a Site-Specific Factor in Differentiation of Mouse Renal Vasculature
HT Yuan, C Suri, DA Landon, GD Yancopoulos, AS Woolf
Journal of the American Society of Nephrology : JASN 2000
Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas
LJ Metheny-Barlow, LY Li
Clinical cancer research 1999
The role of the vascular phase in solid tumor growth: a historical review
D Ribatti, A Vacca, F Dammacco
Neoplasia (New York, N.Y.) 1999
Enhanced expression of Tie2, its ligand angiopoietin-1, vascular endothelial growth factor, and CD31 in human non-small cell lung carcinomas
LJ Metheny-Barlow, LY Li
Clinical cancer research 1999

← Previous 1 2 3 … 7 8 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 17 patents
Referenced in 2 Wikipedia pages
45 readers on Mendeley
See more details